While generally well-tolerated, some patients may experience nausea, vomiting, constipation, diarrhea, or headache
Potential Withdrawal Symptoms When a patient discontinues semaglutide, they may experience a range of withdrawal symptoms including gastrointestinal issues, weight changes, and blood sugar fluctuations
Semaglutide has a long halflife of about one week, so onceweekly injections maintain steady levels
Dipeptidyl peptidase III: a multifaceted oligopeptide N-end cutter: Dipeptidyl peptidase III
The final weight loss number from Phase 3 could be higher than 24.2%, or the plateau could appear early in the extended timeline
Drug interaction studies with psychiatric medications are essential before any clinical use